HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Productivity Initiatives Expected To Yield “Dramatic” Results In ’05

This article was originally published in The Rose Sheet

Executive Summary

Revlon will begin layering productivity enhancement initiatives on top of its existing growth strategy to produce profitable growth, President and CEO Jack Stahl said during a third quarter sales and earnings call Oct. 30. The initiatives will yield "some" positive impact in 2004 and "dramatic" results in 2005, he asserted

You may also be interested in...



Revlon investment

MacAndrews & Forbes, the investment firm owned by Revlon majority investor Chairman Ronald Perelman, will provide company with up to $100 mil. next year to execute its growth plan initiatives, Revlon announces Nov. 14. MacAndrews & Forbes also agrees to provide firm $25 mil. to be available immediately. Investments will be unsecured loans and are "consistent with the progress the company has achieved in strengthening its brands and its relationships with retail customers," the firm states. CEO Jack Stahl announced during Revlon's third quarter sales and earnings call that the company had nearly exhausted its line of credit but remained confident it would find the resources it needs (1"The Rose Sheet" Nov. 3, 2003, p. 7)...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel